Female Reproductive System
Other Names
Synopsis
Female Reproductive System
Overview and Definition
The female reproductive system comprises internal and external organs that facilitate menstruation and procreation. This organ system is responsible for producing gametes (termed eggs or ova), regulating sex hormones, and maintaining fertilized eggs as they develop into mature fetuses ready for delivery. The female reproductive system functions to produce gametes and reproductive hormones, just like the male reproductive system; however, it also has the additional task of supporting the developing fetus and delivering it to the outside world. Unlike its male counterpart, the female reproductive system is located primarily inside the pelvic cavity.
A woman's reproductive years are between menarche (the first menstrual cycle) and menopause (cessation of menses for 12 consecutive months). During this period, cyclical expulsion of ova from the ovary occurs, with the potential for fertilization by male gametes or sperm. This cyclic expulsion of eggs is a normal part of the menstrual cycle.
The female reproductive system undergoes significant physiological changes across life stages, from puberty through menopause, reflecting its adaptability and integration with other body functions. Female reproductive anatomy also influences sexual well-being and creates hormones that regulate a wide variety of functions around the body.
Anatomy: Components and Organs
Internal Organs
The vagina, uterus, ovaries, and uterine tubes compose the internal genital organs.
Ovaries
Ovaries are small, oval-shaped glands that are located on either side of the uterus. The ovaries produce eggs and hormones. The ovaries produce, mature, and discharge the egg cells or ova. Ovarian function is also for the maturation and maintenance of the secondary sex characteristics in females.
The ovary comprises an outer covering of cuboidal epithelium called the ovarian surface epithelium, superficial to a dense connective tissue covering called the tunica albuginea. Beneath the tunica albuginea is the cortex, or outer portion, of the organ. The cortex is composed of a tissue framework called the ovarian stroma that forms the bulk of the adult ovary. Oocytes develop within the outer layer of this stroma, each surrounded by supporting cells. This grouping of an oocyte and its supporting cells is called a follicle. Beneath the cortex lies the inner ovarian medulla, the site of blood vessels, lymph vessels, and the nerves of the ovary.
Fallopian Tubes (Uterine Tubes)
The fallopian tubes are narrow tubes that are attached to the upper part of the uterus and serve as pathways for the egg (ovum) to travel from the ovaries to the uterus. Fertilization of an egg by sperm normally occurs in the fallopian tubes. The fertilized egg then moves to the uterus, where it implants into the uterine lining.
Uterus
The uterus is a hollow, pear-shaped organ that holds a fetus during pregnancy. It is divided into two parts: the cervix and the corpus. The corpus is the larger part of the uterus that expands during pregnancy. In the uterus, hormones promote the growth and maturation of the endometrium. If pregnancy does not occur, the proliferated endometrial lining breaks down and sheds, passing through the vagina.
Cervix
The cervix, situated at the lower end of the uterus, serves as a crucial anatomical gateway between the uterus and the vagina. The neck of the uterus is called the cervix, and it protrudes into the vagina.
Vagina
The vagina is the fibromuscular canal connecting the uterus to the external genitalia, serving as the birth canal during delivery and the passage for menstrual flow. The function of the external female reproductive structures is twofold — to enable sperm to enter the body and to protect the internal genital organs from infectious organisms.
External Genitalia (Vulva)
The external genital organs, or vulva, are held by the female perineum. These are the mons pubis, labia majora and minora, clitoris, vestibule, vestibular bulb, and glands.
- The labia majora, meaning "large lips," enclose and protect the other external reproductive organs. These are relatively large and fleshy and are comparable to the scrotum in males. The labia majora contain sweat and oil-secreting glands.
- The clitoris, rich in nerve endings, is a primary source of sexual pleasure. The clitoris responds to sexual stimulation. When a person experiences arousal, it becomes swollen. It is the main organ responsible for female orgasms.
- The vestibular (Bartholin) glands and Skene glands produce lubricating secretions that maintain a healthy environment in the vaginal and periurethral area. The mons pubis and the perineum provide additional protection to the underlying structures.
Physiological Functions
Gamete Production (Oogenesis)
The ovarian cycle is a set of predictable changes in a female's oocytes and ovarian follicles. The female reproductive system produces hormones and matures eggs (called ova) during the monthly menstrual cycle. Every month, an egg is released from one of the female's ovaries with the potential to become fertilized by male sperm. If fertilization occurs, female hormones develop the fertilized egg into a fetus and, ultimately, a baby ready for delivery in about 40 weeks.
Hormone Production
Estrogen is a steroid hormone responsible for the growth and regulation of the female reproductive system and secondary sex characteristics. Estrogen is produced by the granulosa cells of the developing follicle and exerts negative feedback on LH production in the early part of the menstrual cycle. However, once estrogen levels reach a critical level as oocytes mature within the ovary in preparation for ovulation, estrogen begins to exert positive feedback on LH production, leading to the LH surge through its effects on GnRH pulse frequency.
The ovarian follicle contains two cell types responsible for hormone production — theca cells and granulosa cells. LH stimulates theca cells to produce progesterone and androstenedione by activating the enzyme cholesterol desmolase. Both 17-β estradiol and progesterone are secreted into the bloodstream and affect various tissues, including the uterus and pituitary gland. In the uterus, these hormones promote the growth and maturation of the endometrium.
The Menstrual Cycle
The female reproductive system undergoes regular cyclic changes known as the menstrual cycle, which serves as the body's periodic preparation for ovulation and potential pregnancy. The most noticeable aspect is menstruation, or cyclic vaginal bleeding, which occurs alongside a series of coordinated hormonal shifts. Menstruation typically starts around puberty with a median age of 12.4. Menstrual cycles cease at menopause, which has an average onset around age 51.
The menstrual cycle phases are characterized by predictable fluctuations of ovarian hormones estradiol (E2) and progesterone (P4). The follicular phase derives its name from the maturation of the ovarian follicles containing oocytes. The luteal phase begins with the LH surge and ends with the onset of menses. A typical cycle lasts approximately 28 days. The luteal phase lasts 14 days, and the follicular phase is more variable. Low serum levels of estradiol and progesterone mark the beginning of the follicular phase.
Starting with the first day of menses and ending with the day before the subsequent bleeding onset, the average cycle length is 28 days. However, healthy cycles vary in length between 21 days and 37 days.
At the anterior pituitary, sex steroid hormones provide negative feedback, reducing the secretion of FSH and LH, which subsequently reduces the production of 17-β estradiol and progesterone by the ovaries. An exception to this negative feedback loop occurs around the time of ovulation. When a critical level of 17-β estradiol is reached, it provides positive feedback to the anterior pituitary, leading to a surge in FSH and LH production.
Reproduction and Gestation
Fertilization of an egg by sperm normally occurs in the fallopian tubes. The fertilized egg then moves to the uterus, where it implants into the uterine lining. The uterus then sustains the developing embryo and fetus throughout pregnancy, with profound structural and hormonal changes supporting fetal development and ultimately parturition.
Health Assessment and Markers of Normal Function
Clinical and Gynecological Examination
The menstrual cycle is a crucial indicator of a female's reproductive health, and any abnormalities in menstruation necessitate thorough evaluation. A thorough understanding of menstrual physiology is important for clinicians, as it allows them to diagnose and manage various gynecological issues, including both hormonal and structural pathologies. Moreover, understanding the menstrual cycle is crucial for guiding patients through fertility planning, pregnancy, and the menopausal transition.
Hormonal Assessment
Assessment of the female reproductive system includes a panel of sex hormone measurements. Diagnostic testing includes dehydroepiandrosterone sulfate (DHEAS) to assess for hyperandrogenism; follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, thyroid function, and prolactin to evaluate for hormonal imbalances; and imaging tests such as pelvic ultrasound.
FSH is the hormone responsible for stimulating the growth of ovarian follicles, which contain eggs. An FSH test is usually performed on the second or third day of the menstrual cycle. Low FSH levels may indicate diminished ovarian reserve, while high levels can suggest ovarian dysfunction.
Imaging
Pelvic ultrasound is a non-invasive imaging test that uses sound waves to create detailed images of the reproductive organs, including the uterus, ovaries, and fallopian tubes. Pelvic ultrasounds are typically recommended for women experiencing infertility, irregular periods, pelvic pain, or other reproductive health concerns. They can also be used to monitor fertility treatments or to assess the health of a pregnancy.
Nutritional and Lifestyle Factors Supporting Normal Function
Priority nutrients for women of reproductive age include iron, folate, calcium, vitamin D, zinc, vitamin B12, and long-chain omega-3s (DHA), with supplementation considered when dietary intake or bioavailability is inadequate. Evidence consistently links Mediterranean-style eating to improved metabolic health, insulin sensitivity, IVF success, lower gestational diabetes risk, and favorable neonatal outcomes.
Certain nutrients have critical roles before and during pregnancy and may be underconsumed among pregnant women. These include calcium, choline, folate/folic acid, iodine, iron, magnesium, omega-3 fatty acids, vitamin A, vitamin B6, vitamin B12, vitamin D, and zinc.
Nutrients Studied in Relation to Female Reproductive Health
Folate (Folic Acid / Vitamin B9)
Overview: Folate is a water-soluble vitamin essential for the synthesis of thymidylate and purines and, hence, DNA.
Scientific Evidence: For non-pregnant adult women, the recommended intake is 400 μg/day dietary folate equivalent. For women capable of becoming pregnant, an additional 400 μg/day of synthetic folic acid from supplements or fortified foods is recommended to reduce the risk of neural tube defects (NTD). Micronutrients play a crucial role in reproductive health by supporting oocyte quality, hormonal balance, and implantation processes. By analyzing research from various scientific databases spanning from 2000 to April 2024, the impact of key micronutrients such as folate, vitamin D, iron, selenium, and antioxidants on fertility outcomes was highlighted. Deficiencies in these nutrients have been associated with impaired ovarian function, disrupted menstrual cycles, and increased risk of pregnancy complications. Nutrients like folic acid, omega-3 fatty acids, and antioxidants have shown potential benefits in fertility research, yet conflicting results exist. Evidence for folate's role in NTD prevention is among the most robust in reproductive nutrition and forms the basis of international public health policy.
Vitamin D
Overview: In females, the vitamin D receptor (VDR) is present in the uterus, ovaries, and reproductive tract, as well as in the placenta during pregnancy. Given its widespread distribution, vitamin D plays a pivotal role in reproductive health by regulating processes such as ovarian steroidogenesis, folliculogenesis, and the acrosome reaction.
Scientific Evidence: Observational studies and RCTs suggest that vitamin D supplementation may improve fertility by reducing inflammatory markers and enhancing endometrial receptivity, potentially increasing implantation and pregnancy rates. A systematic review and meta-analysis found that women with vitamin D deficiency had an increased risk of miscarriage compared to those with sufficient levels (odds ratio, 1.94; 95% confidence interval, 1.25–3.02). However, the same analysis noted that whether preconception vitamin D treatment reduces the risk of miscarriage remains unknown. These findings suggest that while vitamin D deficiency is associated with an increased risk of miscarriage, supplementation's effectiveness in preventing miscarriage, particularly in infertile women, is not yet conclusive. Further large-scale, high-quality randomized controlled trials are necessary to establish definitive recommendations.
Regarding dysmenorrhea, an intervention study enrolled forty women with primary dysmenorrhea to assess the effect of a single-loading oral dose of vitamin D on dysmenorrhea. Participants were randomized into two groups. The mean pain score decreased significantly in the experimental group. However, another clinical trial reported that vitamin D therapy did not have a significant impact in lowering dysmenorrhea and pelvic pain in patients with endometriosis diagnosed and treated by laparoscopy. Overall, evidence in this area remains preliminary and mixed.
Iron
Overview: Iron is a critical mineral for oxygen transport and is particularly relevant to women of reproductive age due to losses through menstruation.
Scientific Evidence: This area of research underscores the pivotal role of specific vitamins and minerals such as folate, vitamin D, iron, and antioxidants in enhancing reproductive health. Micronutrients play a crucial role in supporting oocyte quality, hormonal balance, and implantation processes. In infertile women attending an IVF clinic, both red blood cell (RBC) folate and vitamin B12 levels were found to be inadequate overall; in those who used a folic acid supplement, there was a significantly greater likelihood of achieving the threshold for folate sufficiency. Evidence for iron supplementation in the context of menstrual blood loss and reproductive anemia is well-established, though specific large-scale RCT data specific to fertility outcomes require further investigation.
Omega-3 Fatty Acids (DHA / EPA)
Overview: Long-chain omega-3 fatty acids — primarily docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) — are structural components of cell membranes and have anti-inflammatory properties relevant to reproductive tissues.
Scientific Evidence: Nutrient supplementation, including omega-3 fatty acids, is being explored to enhance pregnancy rates, increase live birth rates, and reduce miscarriage rates in females undergoing assisted reproductive technology (ART). Nutrients like folic acid, omega-3 fatty acids, and antioxidants have shown potential benefits, yet conflicting results exist. A short period of dietary intervention containing omega-3 fatty acids and vitamin D was shown in one study to improve the quality of embryo cleavage. Current evidence is promising but not conclusive, with heterogeneous trial designs limiting firm recommendations.
Coenzyme Q10 (CoQ10)
Overview: CoQ10 is a fat-soluble antioxidant involved in mitochondrial energy production, with research interest in oocyte quality.
Scientific Evidence: Live birth rates may be influenced by nutrient supplementation, with coenzyme Q10 and vitamin D showing promise. Miscarriage rates may be reduced with nutrients such as vitamin D, omega-3 fatty acids, and antioxidants. Evidence for CoQ10 in female fertility is largely derived from small RCTs and requires confirmation in larger, more robust trials; current evidence strength is considered preliminary.
Calcium
Overview: Calcium is essential for bone mineral density, muscular function, and hormonal signaling, all of which are relevant across the reproductive lifespan.
Scientific Evidence: Diet influences cardiovascular and bone health through effects on lipids, glycemia, blood pressure, and mineral/vitamin status, with fiber-rich carbohydrates, unsaturated fats (notably olive oil), and adequate calcium–vitamin D emerging as central levers. The NIH ODS identifies calcium as a key nutrient that may be underconsumed during pregnancy, emphasizing the importance of adequate intake throughout the reproductive years.
Herbs and Natural Ingredients Studied in Relation to Female Reproductive Health
Vitex agnus-castus (Chasteberry / Chaste Tree)
Traditional Use
Vitex agnus-castus, commonly known as chasteberry, is a shrub native to the Mediterranean region and parts of Asia. This deciduous plant belongs to the Verbenaceae family and is characterized by violet flowers and berries. Flavonoids, terpenoids, and, most notably, iridoid glycosides contribute to the supportive properties of chasteberry. The historical use of chasteberry has been dated back over 2,000 years to the ancient Greeks, Romans, and Egyptians. Its name reflects the traditional belief that the plant promoted chastity, used by monks to suppress sexual libido. Records note that chasteberry was used in many cultures to support gynecological health, skin health, digestive comfort, and overall well-being. Vitex was also believed to be a supportive tool for lactation in nursing mothers.
Scientific Evidence
A systematic review evaluated the evidence for the efficacy and safety of Vitex extracts from randomized controlled trials investigating women's health. Eight databases were searched. Thirteen randomized controlled trials were identified and twelve were included in the review, of which eight investigated premenstrual syndrome, two premenstrual dysphoric disorder (PMDD), and two latent hyperprolactinaemia.
For premenstrual syndrome, seven of eight trials found Vitex extracts to be superior to placebo (5 of 6 studies), pyridoxine (1), and magnesium oxide (1). In premenstrual dysphoric disorder, one study reported Vitex to be equivalent to fluoxetine, while in the other, fluoxetine outperformed Vitex.
In latent hyperprolactinaemia, one trial reported Vitex to be superior to placebo for reducing TRH-stimulated prolactin secretion, normalising a shortened luteal phase, increasing mid-luteal progesterone and 17β-oestradiol levels, while the other found Vitex comparable to bromocriptine for reducing serum prolactin levels and ameliorating cyclic mastalgia.
The clinical pharmacological effects of Vitex agnus-castus extract are not fully clarified, but are supposed to be due to a dopaminergic activity in the hypothalamic-pituitary-gonadal axis, leading to reduced prolactin secretion and potentially alleviating symptoms of PMS and associated mastalgia/mastodynia. Three-month treatment with Vitex agnus-castus extract substantially decreased the percentage of patients with irregular cycle (from 9.1% to 0.1%) and breast tenderness (from 39.9% to 0.8%). Adverse events with Vitex were mild and generally infrequent. Overall evidence is moderate for PMS symptom relief, with methodological quality noted as variable across included trials.
Black Cohosh (Cimicifuga racemosa)
Traditional Use
Black cohosh has a long history of use. Native Americans used it to treat musculoskeletal pain, fever, cough, pneumonia, sluggish labor, and menstrual irregularities. European settlers used black cohosh as a tonic to support women's reproductive health. Native Americans used black cohosh for treatment of a variety of conditions including kidney ailments, malaria, sore throat, and menstrual cramps. It has also been used medicinally in Germany since the late 19th century.
Scientific Evidence
Today, black cohosh is most commonly used for menopausal symptoms, including hot flashes and night sweats (together known as vasomotor symptoms), vaginal dryness, heart palpitations, tinnitus, vertigo, sleep disturbances, nervousness, and irritability.
Studies have found varying results for the plant's effects on human physiology as to whether, for example, it raises the body's levels of estrogen, which is present in lower levels in menopausal women than in premenopausal women, or whether it affects levels of luteinizing hormone or follicle-stimulating hormone. It is not clear whether black cohosh affects the structure and activity of vaginal and uterine tissues. Some researchers believe that black cohosh might exert its effects through a brain-related action, such as modulation of serotonergic pathways, or through its potential ability to act as an antioxidant, anti-inflammatory, or selective estrogen receptor modulator.
Black cohosh is widely used by many women for the treatment of a range of medical disorders, but solid clinical evidence to back up the claims made by manufacturers is lacking. Studies relating to human physiology have been largely inconclusive. Despite its long-standing use, studies of black cohosh have yielded conflicting data, in part because of lack in study design rigor and the short duration of studies to date. Evidence is characterized as mixed and inconclusive; the NIH NCCIH has funded multiple trials investigating this herb's effects on menopausal symptoms.
Maca (Lepidium meyenii)
Traditional Use
Maca, an Andean plant of the brassica (mustard) family, has been used for centuries in the Andes as an adaptogenic plant to manage anemia, infertility, and female hormone balance.
Scientific Evidence
A systematic review assessed the evidence for and against the effectiveness of the maca plant as a treatment for menopausal symptoms. Researchers searched 17 databases from their inception up to June 2011 and included all randomized clinical trials (RCTs) that compared any type of maca-based intervention to a placebo. All studies were assessed for methodological quality using the Cochrane risk of bias assessment tool. Four RCTs met all inclusion criteria. These RCTs tested the effects of maca on menopausal symptoms in healthy perimenopausal, early postmenopausal, and late postmenopausal women. Using the Kupperman Menopausal Index and the Greene Climacteric Score, all RCTs demonstrated favorable effects of maca.
Evidence is limited by the small number of trials, small sample sizes, and variability in maca preparations and doses used. Evidence is therefore characterized as preliminary but encouraging for menopausal symptom management; the mechanism of action is not fully established and further large, high-quality RCTs are required.
Dong Quai (Angelica sinensis)
Traditional Use
Dong quai has a long history in traditional Chinese medicine (TCM), where it has been used for several thousand years as a primary herb for gynecological complaints including dysmenorrhea, irregular menstruation, and menopausal symptoms. It is often combined with other herbs in classical TCM formulas.
Scientific Evidence
Dong quai has been used for female hormonal balancing in traditional Chinese medicine; however, it does not appear effective for hot flashes and may cause photosensitivity, anticoagulation, and certain cancers. Current clinical evidence for dong quai as a standalone treatment for any female reproductive indication is insufficient, and the available data do not support its efficacy for menopausal vasomotor symptoms. Evidence is considered weak.
Evening Primrose Oil (Oenothera biennis)
Traditional Use
Evening primrose oil, rich in gamma-linolenic acid (GLA), has been traditionally used in Western herbal practice for premenstrual syndrome, mastalgia, and menopausal symptoms.
Scientific Evidence
Evening primrose oil is commonly used to treat inflammatory and autoimmune disorders; it is also used for hot flashes but does not seem to be effective in this regard. Overall, clinical evidence for evening primrose oil across female reproductive indications is limited and does not consistently demonstrate efficacy over placebo in controlled trials.
Associated Conditions and Disorders
Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly release eggs. Prevalences of PCOS range from 4% to 20%. Anovulatory cycles are frequently associated with endocrine and metabolic disorders that impact the hormones involved in the hypothalamic-pituitary-ovarian (HPO) axis, such as polycystic ovary syndrome (PCOS), thyroid disorders, and hyperprolactinemia.
Endometriosis
Endometriosis is a condition where endometrial tissue is found outside of the uterus. Endometriosis is a chronic, estrogen-dependent disease affecting 5–10% of women of reproductive age, rising to nearly 30% among women with infertility. Endometriosis is strongly associated with gynecologic (adenomyosis, uterine fibroids, polycystic ovarian syndrome) and systemic (autoimmune, inflammatory, psychiatric, and neurological) comorbidities that impair women's quality of life and global health through multiple mechanisms, influencing everyday life and work activities.
Uterine Fibroids (Leiomyomas)
Uterine fibroids (leiomyomas) are benign tumors and are highly prevalent in women of reproductive age. Symptoms associated with uterine fibroids most commonly include heavy or prolonged menstrual bleeding, pelvic pressure and pelvic organ compression, back pain, and adverse reproductive outcomes. The prevalence of diagnosis of uterine fibroids is approximately 10% across the female population; importantly, the condition has a high estimated cumulative incidence by onset of menopause, occurring in over 70% of women. Endometriosis and uterine fibroids are estrogen-dependent gynecological disorders with an increasing burden to women's health worldwide.
Amenorrhea
The absence of menstruation in women of reproductive age who have ovaries and a uterus is called amenorrhea. There are two types: primary amenorrhea is the absence of menarche by the age of 16 years; secondary amenorrhea is the absence of menstruation for three or more consecutive cycles in women who previously experienced regular menstrual cycles.
Abnormal Uterine Bleeding (AUB)
Abnormal menstruation and abnormal uterine bleeding (AUB) in reproductive-aged females can arise from various causes. When ovulation does not occur, no corpus luteum develops, and progesterone is not secreted in significant quantities. Without progesterone secretion, the endometrium does not mature, and there is no withdrawal of progesterone to trigger synchronized shedding at the end of the cycle. Meanwhile, estrogen stimulates endometrial growth, causing the proliferative endometrium to thicken. Eventually, it reaches a point where it breaks down and sloughs off, typically at irregular intervals, with menstrual flow varying from scant to heavy.
Infertility and Subfertility
A growing number of studies reveal that infertility and reproductive disorders, such as endometriosis, adenomyosis, polycystic ovary syndrome (PCOS), and uterine fibroids, may have a negative impact on pregnancy, from implantation until term. Many women of reproductive age, particularly those experiencing infertility, may not meet the recommended dietary allowances for key nutrients, which could adversely affect their fertility potential.
Menopause and Perimenopause
Menopause, which typically occurs in women at about 51 years of age, is the cessation of menstruation and the end of a woman's reproductive period. During this time, chronically low levels of steroidal estrogens may lead to a number of short- and long-term medical sequelae such as hot flashes, vaginal dryness, heart disease, and osteoporosis. Estrogen has many other effects that are important for bone health and cardiovascular health in premenopausal patients.
References
- StatPearls — Physiology, Female Reproduction (NCBI Bookshelf)
- StatPearls — Physiology, Menstrual Cycle (NCBI Bookshelf)
- StatPearls — Physiology, Ovulation (NCBI Bookshelf)
- StatPearls — Female Reproductive System Terminology (NCBI Bookshelf)
- StatPearls — Reproductive System Alterations (NCBI Bookshelf)
- StatPearls — Black Cohosh (NCBI Bookshelf)
- DARE Quality-Assessed Review — Vitex agnus-castus extracts for female reproductive disorders (NCBI Bookshelf)
- DARE Quality-Assessed Review — Maca for menopausal symptoms (NCBI Bookshelf)
- NCCIH — Black Cohosh: Usefulness and Safety
- NIH Office of Dietary Supplements — Dietary Supplements and Life Stages: Pregnancy
- NIH Office of Dietary Supplements — Black Cohosh (Health Professional Fact Sheet)
- PMC — How to Study the Menstrual Cycle: Practical Tools and Recommendations
- PMC — The Key Role of Vitamin D in Female Reproductive Health: A Narrative Review
- PMC — Influence of Vitamin D Supplementation on Reproductive Outcomes of Infertile Patients: A Systematic Review and Meta-Analysis
- PMC — Vitamin D and Reproductive Disorders
- PMC — Vitamin D in Reproductive Health Disorders: A Narrative Review
- PMC — Use of Vitex agnus-castus in Patients with Menstrual Cycle Disorders
- PMC — Co-occurrence of Endometriosis and Uterine Fibroids
- PMC — Impact of Nutrition on Female Reproductive Disorders
- PMC — The Role of Diet in Women of Childbearing Age: Current Evidence Supporting Nutritional Recommendations
- PMC — Infertility and Reproductive Disorders: Impact of Hormonal and Inflammatory Mechanisms on Pregnancy Outcome
- PMC — Use of Gelatinized Maca (Lepidium peruvianum) in Early Postmenopausal Women
- PubMed — Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials (Planta Medica, 2013)
- PubMed — Maca (Lepidium meyenii) for Treatment of Menopausal Symptoms: A Systematic Review (Maturitas, 2011)
- PubMed — The Effect of Nutrient Supplementation on Female Fertility: A Systematic Review
- PubMed — Micronutrients and Women of Reproductive Potential: Folate, Vitamin B12, Vitamin B6
- PubMed — Micronutrients and Reproductive Health Issues: An International Perspective
- Wiley / Nursing Research and Practice — Nutritional Interventions for Enhancing Female Fertility: A Comprehensive Review of Micronutrients
- Medscape — Female Reproductive Organ Anatomy: Overview
- PMC — Exploring Self-Reported Symptoms for PCOS, Endometriosis, and Uterine Fibroids
- Clinical and Experimental Obstetrics & Gynecology — Gynaecologic and Systemic Comorbidities in Patients with Endometriosis
Natural Remedies
Ingredients
These ingredients are often used in alternative medicine to support female reproductive system.
- 8-prenylnaringeninScientific
8-Prenylnaringenin (8-PN) from hops (Humulus lupulus) is among the most potent known phytoestrogens, with high affinity for estrogen receptor ERα. Multiple clinical trials of hop extracts standardized to 8-PN have shown modest reductions in menopausal hot flushes and vasomotor symptoms. An animal model also confirmed its ability to reverse ovariectomy-induced hot flush surrogates.
- ALA (alpha-lipoic acid)Scientific
ALA has been studied in polycystic ovary syndrome (PCOS), where it improves insulin sensitivity and metabolic parameters. A 2024 systematic review and meta-analysis of RCTs evaluated ALA's effects on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in PCOS women. A clinical study of ALA plus myo-inositol found 71% of PCOS women experienced improved menstrual cyclicity.
- alfalfaScientific
Alfalfa's phytoestrogens (formononetin, biochanin A, coumestrol) directly interact with estrogen receptors in female reproductive tissues. This pharmacological mechanism underlies its use for menopausal and perimenopausal symptoms. Limited clinical evidence supports phytoestrogen effects on vasomotor symptoms.
- algal oilScientific
Algal oil DHA is recommended for women throughout pregnancy and lactation to support fetal development and infant nutrition. DHA supplementation during pregnancy reduces the risk of very early preterm birth in low-dietary-DHA populations. During breastfeeding, algal oil increases breast milk DHA content and is considered safe and effective for this purpose.
- allspiceScientific
P. dioica leaf extracts bind ERα and ERβ oestrogen receptors and modulate oestrogen-responsive gene expression in cell models, supporting its traditional use for menopausal symptoms and dysmenorrhea in Costa Rica and the Caribbean. A 2018 study confirmed oestrogenic and anti-oestrogenic effects of isolated allspice chromones.
- aniseScientific
Anise is recognized as a phytoestrogenic agent in official monographs (ESCOP, EMA) and has clinical evidence for its effects on hot flashes and dysmenorrhea. Trans-anethole and estrols exert estrogenic activity documented in multiple in vitro, animal, and clinical studies. Traditional use across Unani, Iranian, and Western medicine for women's reproductive health is extensive.
- apple cider vinegarScientific
Human and animal studies support ACV's relevance to the female reproductive system primarily through its effects on insulin sensitivity in PCOS. A small human study (n=7) found ACV restored ovulatory function in PCOS patients; animal models show improved ovarian histoarchitecture. A 2026 RCT (n=94) examined adjunctive ACV in PCOS patients on metformin.
- ashwagandhaScientific
Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen studied for female reproductive health. A 2022 randomized, placebo-controlled trial found 300 mg twice daily for 8 weeks significantly improved female sexual health scores. A 2025 systematic review confirmed its potential to improve sexual function and address certain reproductive disorders via antioxidant mechanisms.
- asparagusScientific
The female reproductive system is the most thoroughly clinically evidenced target system for asparagus (A. racemosus/shatavari). Multiple 2025 RCTs have demonstrated hormonal modulation, improvement of perimenopausal symptoms, vasomotor symptom reduction, menstrual health benefits, and FSH/LH/AMH modulation. Traditional Ayurvedic and Indian/British Pharmacopoeial recognition as a gynecological herb is extensive.
- astaxanthinScientific
Human RCTs demonstrate astaxanthin benefits the female reproductive system in PCOS and endometriosis: it reduces ovarian oxidative stress and ER stress in granulosa cells, improves hormonal and metabolic parameters, and improves oocyte and embryo quality in ART settings. A 2025 systematic review of human trials confirmed benefits in women with PCOS and endometriosis.
- barberryScientific
Barberry/berberine has clinical evidence for effects on the female reproductive system, primarily through PCOS management: reducing androgens, improving insulin resistance, normalizing LH/FSH ratios, and improving reproductive hormonal profiles across multiple RCTs.
- barrenwortScientific
Epimedium icariin acts as a phytoestrogen binding ERα and promoting estrogen synthesis in granulosa cells. It modulates estrus cycles in animal models and has been studied for premature ovarian failure. Traditional TCM use includes menstrual irregularities and postmenopausal conditions. The 24-month bone RCT enrolled postmenopausal women and confirmed safe estrogenic activity in the female reproductive system.
- bee pollenScientific
Bee pollen pollen extracts have been tested in multiple human trials for menopausal symptom relief, with consistent improvements in hot flushes, night sweats, mood, and quality of life. Phytoestrogenic and serotonin-modulating mechanisms have been proposed. Evidence is preliminary but includes several RCTs.
- berberineScientific
Berberine has strong clinical evidence for improving reproductive outcomes in women with PCOS, including increased ovulation rates, improved endometrial thickness, and higher clinical pregnancy rates. It also reduces excess androgens, LH, and insulin resistance—key hormonal dysfunctions in female reproductive disorders.
- beta-caroteneScientific
Beta-carotene is a normal and documented component of human breast milk, with maternal intake directly influencing milk carotenoid concentrations. Maternal vitamin A requirements increase during lactation, and beta-carotene from diet serves as the principal plant-source precursor for this increased need. Supplementation during pregnancy and lactation has been studied in clinical trials in nutrient-deficient populations.
- black cohoshScientific
Black cohosh (Actaea/Cimicifuga racemosa) has long been used by Native Americans for menstrual irregularity and childbirth support. Multiple RCTs and meta-analyses have evaluated it for menopausal vasomotor symptoms; a 2010 meta-analysis of nine placebo-controlled RCTs found black cohosh preparations improved vasomotor symptoms by approximately 26% over placebo. Evidence is inconsistent and a 2012 Cochrane review found insufficient evidence to fully support its use.
- bladderwrackScientific
Bladderwrack modulated estrogen and progesterone levels in a published human case study, prolonged menstrual cycle length, and exhibited anti-estrogenic effects in pre-menopausal women. The mechanism involves reduced cholesterol substrate for estrogen biosynthesis and direct granulosa cell modulation.
- boronScientific
Boron affects the female reproductive system through estrogen and calcium metabolism modulation (documented in postmenopausal women), reduction of menstrual pain (RCT evidence), and intravaginal boric acid use for vaginal infections (clinical evidence). It accumulates in reproductive tissues and influences sex-steroid enzyme pathways.
- bovine liverScientific
Bovine liver provides folate (neural tube defect prevention), B12, heme iron (prevents ovulatory dysfunction and maternal anemia), zinc (folliculogenesis), vitamin A (follicular development), and choline (embryonic brain development). These address the primary nutritional demands across the female reproductive cycle from preconception through lactation.
- caroteneScientific
Beta-carotene as provitamin A supports female reproductive function through vitamin A's essential roles in cell differentiation, embryogenesis, and fetal organogenesis. Vitamin A from beta-carotene is required for normal ovarian function and is essential during the periconceptional period. Beta-carotene is preferred over preformed vitamin A in women of reproductive age due to its self-limiting conversion and absence of teratogenic risk.
- caryophylleneScientific
BCP suppressed endometrial implant growth by over 52% in a rat endometriosis model via anti-inflammatory and pro-apoptotic mechanisms, without affecting fertility or reproductive function.
- cauliflowerScientific
I3C and DIM from cauliflower modulate estrogen metabolism and exert anti-proliferative effects in cervical and breast epithelium. Clinical trial data supports I3C efficacy against cervical intraepithelial neoplasia. Folate in cauliflower is essential for fetal neural tube development, directly relevant to reproductive outcomes.
- chamomileScientific
A 2021 PMC-published systematic review of multiple RCTs concluded that chamomile is an effective treatment for primary dysmenorrhea, reducing both menstrual pain and bleeding volume. A 2022 RCT (n=200) directly compared chamomile sachet to mefenamic acid for primary dysmenorrhea and found comparable outcomes. Chamomile inhibits prostaglandin and leukotriene production in the endometrium, the primary driver of menstrual pain.
- chaste treeScientific
Vitex agnus-castus (chasteberry) is well-documented for female reproductive conditions including PMS, premenstrual dysphoric disorder (PMDD), and hyperprolactinaemia. A systematic review of 12 RCTs found 7 of 8 PMS trials showed Vitex superior to placebo. It reduces prolactin via dopaminergic activity, normalizes luteal phase length, and raises mid-luteal progesterone.
- chinese salvia rootScientific
The female reproductive system is one of the most consistently documented domains for Danshen in both classical TCM and modern clinical practice. It is the single most common diagnosis category for Danshen prescriptions in Taiwan's national health insurance data, covering irregular menstruation, menstrual pain, uterine bleeding, and endometriosis.
- cholineScientific
Estrogen upregulates the PEMT enzyme responsible for endogenous choline synthesis, meaning premenopausal women have lower dietary choline requirements than postmenopausal women. When estrogen falls at menopause, susceptibility to choline deficiency and associated organ dysfunction rises sharply. Choline requirements during pregnancy and the full female reproductive lifespan are strongly modulated by estrogen status.
- chromiumScientific
Chromium has been specifically studied in women with PCOS, the most common endocrine-reproductive disorder in women of reproductive age, with clinical trials examining effects on menstrual regularity, ovulation, androgen levels, and fertility. A 2025 meta-analysis of 10 RCTs (683 women) found benefits for insulin sensitivity and metabolic parameters in PCOS. Evidence for direct improvement in ovulation rates is limited; one RCT found chromium comparable to metformin for insulin sensitivity but not for reducing androgens or improving ovulation.
- cinnamonScientific
Cinnamon is studied in PCOS, the most common female endocrine-reproductive disorder. RCTs and systematic reviews show improvements in menstrual cyclicity, ovarian volume, insulin resistance, and metabolic parameters in PCOS. One RCT also found cinnamon capsules superior to clotrimazole for candidal vaginitis.
- CoQ10 (coenzyme Q10)Scientific
CoQ10 improves oocyte quality, ovarian reserve, and ART (assisted reproductive technology) outcomes by restoring mitochondrial function in aging oocytes. Clinical studies demonstrate CoQ10 enhances ovarian function and embryo quality, particularly in women with diminished ovarian reserve or advanced maternal age. A 2025 PMC review synthesizes evidence for its role in oocyte maturation, embryonic development, and ovarian aging.
- d-alpha tocopherolScientific
D-alpha tocopherol is recognized as essential for reproductive health by the NIH, and human studies document its role in endometrial receptivity, uterine blood flow, and implantation support. Pilot clinical data show improved endometrial thickness and pregnancy rates in women with thin endometrium when treated with vitamin E.
- daidzeinScientific
Daidzein is a soy isoflavone with estrogen receptor binding activity. It is metabolized by intestinal bacteria to equol (in equol producers), a more potent phytoestrogen. Clinical evidence supports its role in reducing menopausal vasomotor symptoms, and it is also studied for menstrual cycle support. Multiple RCTs of soy isoflavone products containing daidzein show efficacy for hot flushes.
- daidzinScientific
Daidzein (daidzin's active metabolite) influences female reproductive processes including ovarian cycle, folliculogenesis, oogenesis, and ovarian cell function via phytoestrogenic ERβ agonism. Clinical evidence for menopausal symptom relief exists, though effects on reproduction are mostly from animal and in vitro studies.
- DHA (docosahexaenoic acid)Scientific
DHA and EPA are associated with improved fertility outcomes in women, including higher pregnancy rates in both assisted reproductive technology (ART) and natural conception, and better oocyte and embryo quality. Omega-3 intake during pregnancy supports fetal neurological development and is associated with reduced pregnancy loss. A meta-analysis found significantly higher odds of pregnancy and fertilization with omega-3 supplementation.
- DHEA (dehydroepiandrosterone)Scientific
DHEA is the primary precursor for estrogen and androgen synthesis in postmenopausal women and plays a central role in female reproductive endocrinology throughout the lifespan. Intravaginal DHEA is FDA-approved for menopausal dyspareunia. DHEA supplementation improves ovarian reserve markers and fertility outcomes in women with diminished ovarian reserve.
- DIM (diindolylmethane)Scientific
Diindolylmethane (DIM) is the principal stomach-derived metabolite of Indole-3-Carbinol from cruciferous vegetables. It modulates estrogen metabolism favoring 2-hydroxylation over 16α-hydroxylation, relevant to estrogen-dependent female conditions including endometriosis, uterine fibroids, and cervical health. Clinical evidence supports effects on urinary estrogen metabolite ratios and hormone-sensitive conditions.
- docosahexaenoic acidScientific
DHA is a critical nutrient for the female reproductive system, supporting fetal development via placental transfer during pregnancy, enriching breast milk during lactation, and potentially modulating uterine inflammatory responses. Adequate DHA during pregnancy and lactation is associated with improved infant neurodevelopmental and visual outcomes.
- dodderScientific
Dodder (Cuscuta chinensis) is the most commonly prescribed herb for female infertility in TCM clinical practice. Pharmacological data confirm estrogen-like activity, increased LH receptor binding in ovarian tissue, and anti-abortion effects via MAPK and estrogen/progesterone receptor modulation. Clinical studies of TCM formulas containing dodder show benefits for menstrual disorders, recurrent miscarriage, and ovarian reserve.
- EGCG (epigallocatechin gallate)Scientific
EGCG supports female reproductive health by improving oocyte maturation and developmental capacity, reducing oxidative stress in reproductive tissues, modulating ovarian function, and demonstrating inhibitory effects on gynecological cancers. It has also been studied in preeclampsia and bladder overactivity associated with ovarian hormone deficiency.
- eicosapentaenoic acidScientific
EPA modulates prostaglandin synthesis in the female reproductive system, reducing dysmenorrhea and PMS symptoms. During pregnancy, EPA contributes anti-inflammatory and lipid-regulatory benefits. EPA's role is primarily anti-inflammatory through prostaglandin pathway competition with arachidonic acid.
- EPA (eicosapentaenoic acid)Scientific
EPA-containing omega-3 supplementation has demonstrated clinical benefit for multiple female reproductive outcomes, including reduced androgen levels in PCOS, more regular menstrual cycles, and improved clinical pregnancy rates in women with PCOS undergoing ovulation induction. Maternal EPA status during pregnancy also influences fetal development.
- estrogenScientific
Estrogen is the primary female sex hormone governing the menstrual cycle, female secondary sexual characteristics, bone density, and menopausal symptom management. FDA-approved estrogen therapy is the gold standard for menopausal vasomotor symptoms and vaginal atrophy. It is also the basis of hormonal contraception and HRT.
- fennelScientific
The female reproductive system is the most extensively studied target for fennel's clinical effects. RCTs document efficacy for dysmenorrhea, PMS, and menopausal symptoms. Animal data demonstrate estrogenic effects on uterus, ovaries, and reproductive organs.
- fenugreekScientific
Fenugreek (Trigonella foenum-graecum) is used in Ayurvedic and traditional medicine as a galactagogue and for female hormonal support. Its steroidal saponins (including diosgenin) bind estrogen receptors. Clinical evidence supports its use for lactation support; preliminary evidence exists for menstrual cycle regulation and menopausal symptoms. It is also evaluated in PCOS management.
- ferula assafoetidaScientific
Asafoetida is a documented emmenagogue and reproductive tonic in Ayurvedic, Unani, Persian, and Malaysian medicine. A human RCT compared 1 g/day asafoetida versus oral contraceptive in PCOS patients measuring menstrual regularity, testosterone, and ovarian morphology.
- fisetinScientific
Fisetin modulates ovarian aging, PCOS, endometriosis, uterine fibroids, and menopause pathways through antioxidant, anti-inflammatory, and senolytic mechanisms. A 2026 Johns Hopkins systematic review covers all reproductive contexts comprehensively.
- fish oilScientific
Fish oil EPA and DHA influence female reproductive function through effects on uterine blood flow, endometrial receptivity, hormonal regulation, ovarian follicular development, and prostaglandin profiles governing uterine contractility. Clinical evidence supports fish oil use for improved fertility, PCOS management, dysmenorrhea, and pregnancy outcomes.
- flaxseedScientific
Flaxseed is the richest dietary source of lignans (secoisolariciresinol diglucoside) and also contains phytoestrogens and omega-3 ALA. Clinical studies show supplementation can improve hormonal parameters, reduce androgen levels, and support menstrual cycle regularity in PCOS. Lignans modulate estrogen metabolism via aromatase inhibition and estrogen receptor binding.
- folic acidScientific
Folic acid (vitamin B9) is scientifically established for female reproductive health, primarily as a periconceptional supplement to prevent neural tube defects. Evidence also supports its role in PCOS management, reducing BMI and homocysteine, and improving fertility outcomes when combined with myo-inositol. WHO and NIH formally recommend it for preconception use.
- folinic acidScientific
Folate, including folinic acid, is essential for the female reproductive system through its role in oocyte quality, embryogenesis, and neural tube closure in early fetal development. The one-carbon cycle supported by folinic acid regulates epigenetic programming of the embryo. Folate deficiency is associated with subfertility, early pregnancy loss, and NTD-affected pregnancies.
- formononetinScientific
Formononetin is a phytoestrogenic isoflavone found in red clover and astragalus with preferential ERβ activity. It is metabolized to daidzein and further to equol, contributing to red clover's clinically studied menopausal and reproductive effects. Evidence from red clover RCTs encompassing formononetin shows improvements in menopausal symptoms, vaginal cytology, and bone markers.
- gamma oryzanolScientific
Gamma oryzanol exerts effects on the female reproductive system primarily through pituitary LH suppression and hypothalamic endorphin stimulation, reducing vasomotor symptoms of menopause and perimenopause. Clinical trials in menopausal and surgically oophorectomized women demonstrate 67–85% symptom response rates.
- genisteinScientific
Genistein is the principal soy isoflavone and a potent phytoestrogen with preferential ERβ binding. Multiple RCTs support its use for menopausal vasomotor symptoms and bone protection. A meta-analysis of soy isoflavone trials (in which genistein is the primary active component) shows ~26% improvement in vasomotor symptoms over placebo.
- geraniumScientific
Geranium is classified as phytoestrogenic and adrenal-stimulating, with documented effects on salivary estrogen levels in women. Clinical evidence supports its use in PMS, menopause, and menstrual disorders. It is one of the most widely used botanicals in women's hormonal health aromatherapy.
- gingerScientific
Ginger (Zingiber officinale) has traditional and scientific support for female reproductive use, primarily for dysmenorrhea and pregnancy-related nausea. Multiple RCTs show ginger powder (500 mg–2 g/day) significantly reduces menstrual pain comparable to ibuprofen. It also has anti-prostaglandin effects relevant to uterine cramping.
- ginsengScientific
Panax ginseng has been studied for menopausal quality-of-life improvement and female sexual function. An RCT found Korean red ginseng significantly improved FSH levels, menopause-specific quality of life, and sexual function in postmenopausal women. Ginsenosides modulate estrogen receptor activity and are phytoestrogenic at low concentrations.
- ginsenosidesScientific
Ginsenosides are the primary bioactive triterpene saponins of Panax ginseng, demonstrating phytoestrogenic ERα/ERβ binding at low concentrations. Clinical studies using ginsenoside-standardized ginseng extracts show improvements in menopausal quality of life, FSH levels, and sexual function in postmenopausal women.
- GLA (gamma linolenic acid)Scientific
GLA (via evening primrose oil) has clinical evidence for supporting female reproductive health through reduction of menstrual cramps, PMS symptoms, menopausal hot flashes, and mastalgia. Multiple controlled trials document these effects, with the mechanism involving PGE1 modulation of uterine smooth muscle and hormonal symptom pathways.
- glycitinScientific
Glycitin is a phytoestrogen that directly influences the female reproductive system through ERα and ERβ modulation. In postmenopausal women, soy isoflavone preparations containing glycitin alleviate vasomotor symptoms and are investigated for effects on uterine health, bone, and hormonal balance. Estrogenic effects on the female reproductive system are among the primary documented health functions of glycitin.
- HMR (7-hydroxymatairesinol)Scientific
HMR has been shown to inhibit ENNG-induced uterine endometrial carcinogenesis in rats, significantly reducing endometrial adenocarcinoma incidence. It also modulates estrogen metabolism in pre- and post-menopausal women, shifting the 2-OHE to 16α-OHE ratio favorably. Its phytoestrogenic activity affects reproductive organ responses in animal models.
- HMR lignanScientific
HMRlignan's primary studied application involves the female reproductive endocrine axis: its metabolite enterolactone modulates ERα and ERβ, reduces hot flash frequency in postmenopausal women, inhibits aromatase, and has been studied in uterine carcinogenesis animal models. The one published human RCT specifically enrolled postmenopausal women and showed significant hot flash reduction and robust enterolactone bioconversion.
- hopsScientific
8-Prenylnaringenin (8-PN) from hops is the most potent phytoestrogen known, binding estrogen receptor-alpha with high affinity and producing estrogenic effects on the female reproductive system. Clinical RCTs confirm vasomotor symptom relief in menopause. Safety concerns include potential uterotrophic effects with prolonged use.
- hydroxymatairesinolScientific
HMR is converted by gut microbiota to enterolactone, a weak phytoestrogen that modulates ER-α and ER-β signaling in estrogen-sensitive tissues. A clinical study in postmenopausal women demonstrated that HMRlignan supplementation (36–72 mg/day for 8 weeks) raised plasma enterolactone and significantly reduced hot-flash frequency. ENL may also inhibit aromatase, modestly reducing local estrogen biosynthesis relevant to the female reproductive system.
- icariinScientific
Icariin is the principal flavonoid of Epimedium species (horny goat weed) with demonstrated ERβ phytoestrogenic activity and PDE-5 inhibition. A 24-month RCT found icariin 60 mg/day significantly attenuated postmenopausal bone loss. Preclinical studies confirm estrogenic and anti-osteoporotic effects relevant to female reproductive aging.
- indole-3-carbinolScientific
Indole-3-Carbinol (I3C) is a glucosinolate breakdown product from cruciferous vegetables that modulates estrogen metabolism by shifting 16α-hydroxylation toward the less potent 2-hydroxylation pathway. This affects estrogen-dependent conditions including endometriosis, uterine fibroids, cervical dysplasia (HPV-related), and estrogen-receptor-positive cancers. Clinical trials support it for cervical dysplasia.
- inositolScientific
Inositol (particularly myo-inositol) has robust clinical evidence for female reproductive support in PCOS, improving insulin sensitivity, ovulation, menstrual regularity, and oocyte quality. Multiple RCTs show it restores spontaneous ovulation in PCOS women. A 2024 umbrella review of meta-analyses confirmed its benefits for PCOS-related reproductive dysfunction.
- iodineScientific
Iodine accumulates in ovarian tissue, breast tissue, uterus, and cervix; it is not restricted to the thyroid in females. Thyroid hormones regulated by iodine control menstrual regularity, ovulation, and fertility. Iodine deficiency is associated with menstrual irregularities, impaired ovulation, and increased risk of miscarriage. Adequate iodine is also required during pregnancy for fetal thyroid development and placental function.
- ironScientific
Iron plays a unique and well-characterized physiological role in the female reproductive system. Menstruation is a primary cause of iron loss in women, making iron deficiency the leading nutritional deficiency among women of reproductive age. Iron is required for normal ovarian hormone synthesis, menstrual cycle regulation, endometrial function, and fertility. Iron requirements increase substantially during pregnancy, and dysregulation of iron—either deficiency or overload—is documented in numerous gynecological conditions.
- isoflavonesScientific
Isoflavones are phytoestrogens found in soy, red clover, and other legumes that bind estrogen receptors ERα and ERβ. Multiple systematic reviews and RCTs support their efficacy for menopausal vasomotor symptoms, bone mineral density, and vaginal health. EFSA (2015) confirmed long-term safety at up to 150 mg/day for hormone-sensitive tissues.
- kaleScientific
Kale's I3C and DIM modulate hepatic estrogen metabolism, shifting it toward less proliferative 2-OHE1 metabolites. Epidemiological studies link high cruciferous vegetable intake to reduced risk of hormone-related gynecological cancers. Folate in kale is essential for fetal neural tube development in early pregnancy.
- kavaScientific
Kava has been studied in controlled clinical trials in perimenopausal and postmenopausal women, demonstrating significant reductions in anxiety, mood disturbance, and neurovegetative complaints associated with the reproductive hormonal transition. Clinical herbalist literature also documents traditional use for menstrual cramps and pelvic pain via antispasmodic mechanisms.
- krill oilScientific
A double-blind RCT (Sampalis et al., 2003; n=70 women) demonstrated Neptune Krill Oil (2 g/day, 3 months) significantly reduced PMS symptoms and dysmenorrhea pain and decreased analgesic use, outperforming fish oil. EPA-derived prostaglandins and resolvins reduce uterine prostaglandin-mediated inflammation underlying both conditions.
- kudzuScientific
Kudzu root isoflavones exert phytoestrogenic effects via ERβ with documented clinical relevance to menopause, vaginal health, and menopausal symptom management. Multiple clinical studies, including an RCT, confirm meaningful effects on vasomotor symptoms and vaginal tissue. Estrogenic activity on the female reproductive system is one of kudzu's best-documented human endpoints.
- labisia pumilaScientific
Labisia pumila (Kacip Fatimah) is a Malaysian traditional herb used for postpartum care, menstrual regulation, and female reproductive support. Preclinical and limited clinical studies show phytoestrogenic activity and effects on uterine health. It is registered as a traditional medicine in Malaysia and has been studied in clinical trials for postpartum uterine involution and menopausal symptoms.
- lactobacillus acidophilusScientific
Lactobacillus acidophilus is a dominant species in healthy vaginal microbiome, producing lactic acid to maintain low vaginal pH and protect against pathogenic organisms (BV, candidiasis). Clinical trials of oral and vaginal L. acidophilus supplementation show benefits for bacterial vaginosis treatment and prevention and for maintaining vaginal health.
- lactobacillus crispatusScientific
Lactobacillus crispatus is the predominant species in the optimal healthy vaginal microbiome Community State Type I, providing robust protection against BV and STIs through high hydrogen peroxide and lactic acid production. Clinical studies show vaginal L. crispatus supplementation significantly reduces BV recurrence and cervical cancer risk.
- lactobacillus fermentumScientific
Lactobacillus fermentum is found in the healthy vaginal microbiome and has been studied for BV prevention and vaginal health restoration. Clinical and preclinical evidence supports its role in producing lactic acid and bacteriocins that protect vaginal epithelium. Included in multi-strain probiotic formulations for female reproductive health.
- lactobacillus gasseriScientific
Lactobacillus gasseri is a vaginal Lactobacillus species associated with healthy vaginal microbiome and studied for BV prevention and endometriosis. An RCT found L. gasseri OLL2809 significantly reduced menstrual pain in women with endometriosis. It also colonizes the vaginal tract and contributes to protective lactic acid production.
- lactobacillus jenseniiScientific
Lactobacillus jensenii is a normal vaginal Lactobacillus species that produces both D- and L-lactic acid and hydrogen peroxide, contributing to vaginal protective microbiome. Its presence in healthy vaginal microbiome Community State Types is associated with reduced BV and STI risk. Included in probiotic formulations for vaginal health.
- lactobacillus reuteriScientific
Lactobacillus reuteri has been clinically studied for female reproductive health, including BV treatment (combined with L. rhamnosus) in multiple RCTs, showing improved cure rates and reduced recurrence. The strain RC-14 specifically colonizes the vaginal tract after oral administration and has demonstrated efficacy for BV in controlled clinical trials.
- lactobacillus rhamnosusScientific
Lactobacillus rhamnosus GR-1, combined with L. reuteri RC-14, has demonstrated efficacy in multiple RCTs for BV treatment and prevention, normalizing vaginal microbiome and reducing Nugent scores. It colonizes the vaginal tract after oral ingestion and is one of the most rigorously studied probiotics for female reproductive health.
- lactobacillus salivariusScientific
Lactobacillus salivarius has been found in both vaginal and oral microbiomes and studied for female reproductive health including mastitis prevention and vaginal health. Specific strains (CECT5713) demonstrated efficacy in RCTs for reducing mastitis incidence in breastfeeding women, and vaginal strains contribute to protective microbiome maintenance.
- lactoferrinScientific
Lactoferrin is extensively studied in pregnancy for treatment of iron-deficiency anemia and inflammation, with meta-analysis evidence from 4 RCTs (600 women) favoring it over ferrous sulfate. It also has documented antimicrobial and microbiota-modulating roles in the female genital tract, and vaginal administration has been shown to reduce amniotic fluid oxidative stress.
- lavenderScientific
Multiple RCTs confirm lavender aromatherapy significantly reduces primary dysmenorrhea pain, nausea, and associated symptoms. Lavender in vitro studies demonstrate antifungal activity against vaginal Candida albicans. Aromatherapy massage with lavender is also documented to reduce menopausal symptoms including hot flushes, depression, and pain in climacteric women.
- lemon balmScientific
Lemon balm has clinical evidence for effects on the female reproductive system: RCTs demonstrate reduction of primary dysmenorrhoea severity, improvement of premenstrual symptoms, and improvement of sexual dysfunction (desire, arousal, lubrication, orgasm). Traditional use for menstrual irregularities is also documented in the NIH LactMed database and multiple pharmacopoeias.
- licorice rootScientific
Licorice root's phytoestrogenic compounds directly interact with estrogen receptors in female reproductive tissues. Clinical evidence supports efficacy for menopausal hot flashes (double-blind RCT) and PMS/dysmenorrhea (clinical trial evidence in combination formulas). Authoritative reviews list female reproductive indications as primary uses for glycyrrhizin-containing licorice.
- lignansScientific
Lignans as phytoestrogens influence female reproductive health through modulation of estrogen receptor signaling, SHBG levels, and enterohepatic estrogen circulation. Human studies demonstrate effects on menstrual cycle length, menopausal symptom severity, and estrogen metabolite profiles. Lignans may help prevent estrogen-dependent gynecological cancers and support hormonal balance across reproductive life stages.
- ligustilidesScientific
Ligustilides (particularly Z-ligustilide) are phthalide compounds found in Ligusticum chuanxiong and Angelica sinensis, identified as key bioactive components mediating uterine antispasmodic, vasodilatory, and anti-inflammatory effects. Preclinical studies confirm calcium channel antagonism in uterine smooth muscle. They are principal compounds in TCM formulas for dysmenorrhea.
- macaScientific
Maca (Lepidium meyenii) is a Peruvian root with traditional use for fertility, hormone balance, and sexual function. Several clinical trials show improvements in menopausal symptoms, sexual function, and hormonal profiles (FSH/LH). It works through HPA axis modulation rather than direct phytoestrogenic activity, supporting ovarian and pituitary function.
- magnesiumScientific
Magnesium has multiple clinically documented roles in female reproductive health. It is a standard-of-care treatment for eclampsia (seizures in pre-eclampsia) via IV magnesium sulfate. Serum magnesium is significantly lower in women with pre-eclampsia versus normotensive pregnant women. Magnesium supplementation has also been studied for premenstrual syndrome (PMS) and dysmenorrhea, with RCTs showing reductions in PMS symptoms and menstrual pain.
- magnoliaScientific
Magnolia bark extract has been clinically studied in multiple RCTs in menopausal and postmenopausal women, showing improvements in insomnia, anxiety, mood, irritability, and libido attributable to the magnolia component. Traditional use includes menstrual disorders. Preliminary evidence suggests modulation of sex hormone balance.
- maitake mushroomScientific
Maitake SX-fraction demonstrated the ability to induce ovulation in PCOS patients in a published clinical trial, working via insulin sensitization to correct the hyperinsulinemia-driven androgen excess underlying anovulation. This is the only medicinal mushroom with published clinical ovulation-induction data in women.
- manganeseScientific
The NIH ODS and peer-reviewed literature confirm manganese's role in reproduction via its metalloenzyme functions. Population studies link manganese to menstrual cycle symptoms, and it is included in reviews of minerals essential to female reproductive health.
- marjoramScientific
Marjoram has the strongest direct clinical evidence among herbal remedies for PCOS, with a double-blind RCT demonstrating hormonal improvements. Traditional use as an emmenagogue, menstrual regulator, and antispasmodic for menstrual pain is extensively documented.
- mugwortScientific
A. vulgaris has been used for gynecological conditions for centuries and is listed in the European and French Pharmacopoeias for irregular cycles and menopausal symptoms. Moxibustion RCTs demonstrate statistically significant efficacy for correcting breech presentation. Estrogenic and uterotonic pharmacological activities are confirmed in preclinical studies.
- muira puamaScientific
A clinical study in 202 women using a muira puama-ginkgo combination (Herbal vX) demonstrated significant improvement in multiple sexual function and libido parameters. Traditional use also encompasses menstrual disorders. The clinical evidence is limited to a single non-placebo-controlled study and combination-product design.
- NAC (N-acetyl cysteine)Scientific
NAC has robust clinical evidence in the female reproductive system, particularly for PCOS-related infertility. A systematic review and meta-analysis of 8 RCTs (n=910 women with PCOS) found that NAC significantly improved pregnancy and ovulation rates compared to placebo. A 2025 meta-analysis of 22 studies (n=2515) confirmed improvements in follicular growth, endometrial thickness, and hormone levels.
- nut grassScientific
C. rotundus is arguably the most pharmacologically investigated herb for the female reproductive system in Ayurveda and TCM. It demonstrates antispasmodic, anti-inflammatory, and hormonal modulating effects on the uterus and ovaries, with clinical validation for dysmenorrhea and mechanistic data for fertility and uterine bleeding.
- omega-3 fatty acidsScientific
Omega-3 fatty acids modulate prostaglandin synthesis and steroidogenesis relevant to ovulation, menstrual regularity, and oocyte quality. Clinical studies show benefits in PCOS (reduced free androgen index, improved menstrual regularity), and systematic reviews suggest associations with oocyte quality in ART settings. Evidence for direct fertility outcomes remains preliminary.
- ostholeScientific
Osthole is the principal bioactive coumarin of Cnidium monnieri with demonstrated phytoestrogenic activity at ERα and ERβ. Preclinical studies show it improves ovarian function, induces ovulation, and reduces cyst formation. Preliminary clinical data from TCM-based studies support use in PCOS and anovulatory infertility.
- paeoniflorinScientific
Paeoniflorin is the principal bioactive monoterpene glycoside of Paeonia lactiflora (white peony root), used in TCM for dysmenorrhea, PCOS, and menstrual irregularity. It inhibits ovarian testosterone production via P450c17 suppression and modulates GnRH/LH signaling. Japanese clinical studies using paeoniflorin-containing Kampo formulas show improvements in PCOS and anovulation.
- palmitateScientific
Vitamin A palmitate (as retinoic acid) is essential for embryological development and plays a role in folliculogenesis and uterine function. During pregnancy, adequate retinyl palmitate intake is required for normal fetal organogenesis, while excess intake is teratogenic.
- phytoestrogensScientific
Phytoestrogens are plant-derived compounds (isoflavones, lignans, coumestans) that bind estrogen receptors and modulate estrogenic activity. Multiple systematic reviews and RCTs support their use for menopausal vasomotor symptoms, vaginal health, bone density, and fertility-related hormonal balance. Soy and red clover isoflavones are the most rigorously studied sources.
- pineScientific
Pycnogenol has been studied in RCTs for dysmenorrhea, endometriosis, and menopausal symptoms. A randomized double-blind trial in 200 peri-menopausal women showed significant changes in LDL and HDL cholesterol. Preliminary clinical data indicate reduction in pelvic pain associated with endometriosis and menstrual cramps. The 2024 review of 39 RDP trials confirms women's health as a documented benefit domain.
- pine barkScientific
Pycnogenol has documented clinical evidence across multiple female reproductive applications: menstrual cramp relief (RCTs), endometriosis symptom reduction (clinical studies), and menopausal symptom alleviation (two large RCTs). Patent protection exists for its use in dysmenorrhea. The extract does not exert estrogenic activity.
- pomegranateScientific
Pomegranate has clinical evidence for effects on the female reproductive system: improving PCOS hormonal and metabolic parameters, reducing menopausal symptoms (hot flashes, FSH), and supporting estrogen-related activity via phytoestrogens in pomegranate seed oil. RCTs and meta-analyses document these effects across reproductive lifecycle stages.
- pregnenoloneScientific
Pregnenolone is the biochemical precursor to all female sex steroids (progesterone, estrogens, DHEA), produced in ovaries and adrenal glands. Its adequate supply is essential for ovulation, luteal function, and hormonal balance throughout the reproductive lifespan and into menopause.
- progesteroneScientific
Progesterone is an endogenous steroid hormone and pharmaceutical agent with fundamental roles in the female reproductive cycle, implantation, pregnancy maintenance, and menopausal hormone therapy. FDA-approved bioidentical progesterone (Prometrium) is used in HRT, luteal phase support in IVF, and prevention of preterm birth. Natural progesterone creams are also widely used.
- red cloverScientific
Red clover (Trifolium pratense) is a significant phytoestrogen source containing formononetin, biochanin A, daidzein, and genistein. Multiple RCTs have shown red clover isoflavone supplementation (40–80 mg/day) significantly reduces menopausal hot flushes and improves vaginal cytology. A meta-analysis confirmed its efficacy for vasomotor symptoms versus placebo.
- resveratrolScientific
Human RCT evidence supports resveratrol's role across multiple domains of female reproductive health, including menopause symptom management and PCOS. A meta-analysis of 4 PCOS RCTs showed significant reductions in testosterone, LH, and DHEAS. RESHAW documented broad postmenopausal benefits. Resveratrol's phytoestrogenic activity provides the primary mechanistic rationale.
- rhubarbScientific
Rhubarb has scientific evidence for effects on the female reproductive system, particularly for menopausal and perimenopausal symptoms through ERβ agonism. Clinical use for endometriosis (via blood-stasis resolution) is documented in TCM formulas. Multiple RCTs confirm Siberian rhubarb extract efficacy on hot flashes, anxiety, and sleep in peri/post-menopausal women.
- rhubarb rootScientific
Rhubarb root extract ERr 731 (from Rheum rhaponticum) acts as a selective ERβ agonist, with multiple human RCTs demonstrating efficacy across the full spectrum of perimenopausal and menopausal symptoms. The female reproductive system is among the most robustly evidenced organ targets for rhubarb in clinical research.
- roseScientific
Rosa damascena has the most extensive evidence among rose preparations for female reproductive health. RCTs support its use for primary dysmenorrhea (comparable to mefenamic acid), PMS, menopause symptoms (depression, anxiety, stress, sexual function), and irregular cycles (traditional). Multiple systematic reviews confirm these reproductive health effects.
- royal jellyScientific
RJ binds estrogen receptors α and β, supporting folliculogenesis, endometrial health, and menopausal symptom management. RCTs confirm benefit for vaginal atrophy, menopausal symptoms, and menstrual regularity in PCOS. Animal data show restoration of normal ovarian follicular cycles under hormonal disruption.
- rubia cordifoliaScientific
R. cordifolia has documented use in the clinical treatment of abnormal uterine bleeding (AUB) and primary dysmenorrhea within traditional Asian medicine systems, supported by network pharmacology and experimental studies. Its mechanisms include COX-2 and cPLA2 inhibition, improvement of blood clotting via the coagulation cascade, and anti-inflammatory activity via mollugin. Multiple prescriptions are used clinically in China for gynecological conditions.
- safflowerScientific
Safflower is one of the oldest documented gynecological herbs in TCM, Ayurveda, and Persian medicine, used for dysmenorrhea, amenorrhea, postpartum abdominal pain, and menstrual irregularity. In TCM, it is indicated for amenorrhea due to blood stasis, dysmenorrhea, and postpartum lochioschesis. Animal studies demonstrate a dose-dependent uterotonic effect, with safflower extract increasing contraction frequency and amplitude of uterine smooth muscle in dogs, rats, and mice. Traditional use and uterotonic pharmacology are well-documented in PMC reviews.
- saffronScientific
Saffron (Crocus sativus) has been studied in multiple RCTs for PMS and PMDD, showing significant reductions in mood symptoms. A systematic review and meta-analysis confirmed its efficacy for PMS symptom relief. Active compounds crocin and safranal modulate serotonin reuptake, relevant to premenstrual mood dysregulation.
- sageScientific
Clinical RCTs confirm sage's efficacy in reducing menopausal hot flashes, night sweats, and associated vasomotor symptoms in postmenopausal women. A systematic review with meta-analysis and multiple RCTs support phytoestrogenic and anti-dopaminergic mechanisms. Traditional use for menstrual regulation is also well-documented.
- schisandraScientific
A 2016 randomized, double-blind, placebo-controlled trial (Climacteric, 19(6):574–580) in 36 women aged 40–70 found Schisandra extract (BMO-30) reduced the Kupperman Index by 41.2% vs. 27.2% for placebo at 12 weeks, significantly relieving hot flushes, sweating, and palpitations. Clinical research has also been conducted for polycystic ovary syndrome.
- secoisolariciresinol diglucosideScientific
Secoisolariciresinol diglucoside (SDG) is the principal lignan of flaxseed, converted by gut bacteria to the bioactive enterolignans enterodiol and enterolactone, which act as weak phytoestrogens via ERα/ERβ binding. Clinical studies show SDG from flaxseed supports menopausal symptom relief and PCOS hormonal parameters. Flaxseed is the richest dietary source.
- sesameScientific
Sesame lignans are converted to enterolactone, a phytoestrogen that weakly modulates estrogen receptors and SHBG — directly relevant to female reproductive hormonal balance. A 5-week clinical study in 24 postmenopausal women found hormone status improvements with 50 mg/day sesame. Ayurvedic and TCM traditions extensively document sesame's role in supporting female reproductive health across the lifecycle.
- soyScientific
Soy foods and extracts contain phytoestrogenic isoflavones (genistein, daidzein) scientifically supported for menopausal vasomotor symptoms, bone protection, and lipid management in peri- and postmenopausal women. Multiple systematic reviews and RCTs confirm modest but significant benefits. EFSA has confirmed long-term safety up to 150 mg isoflavones/day.
- soy isoflavonesScientific
Soy isoflavones (primarily genistein and daidzein) are phytoestrogens with ERα/ERβ binding activity. Numerous RCTs support their use for menopausal vasomotor symptoms, with a 2009 systematic review of 17 trials showing consistent reductions in hot flush frequency. EFSA (2015) concluded long-term intake up to 150 mg/day is safe for hormone-sensitive tissues.
- soybeanScientific
Soy isoflavones exert documented effects on the female reproductive system via phytoestrogenic activity, with clinical evidence for effects on menopausal vasomotor symptoms, bone density, and endometrial tissue. They have been used as an alternative to hormone replacement therapy for perimenopausal and postmenopausal symptom management. The efficacy and safety of soy isoflavones for preventing endometrial cancer are not established.
- spearmint leafScientific
Spearmint has clinically confirmed anti-androgenic effects in women, reducing free and total testosterone while raising LH, FSH, and estradiol. These effects have direct implications for PCOS management, hirsutism, and hormonal balance in the female reproductive system.
SPMs are produced in peritoneal fluid and endometrial tissue, with reduced levels documented in endometriosis patients. Human placenta constitutively biosynthesizes SPMs. SPMs regulate uterine inflammation and may influence reproductive outcomes.
- st. john's wortScientific
SJW has been clinically studied for perimenopausal and postmenopausal symptoms, with RCT evidence for reduction in hot flash frequency and severity, and for improvement in postmenopausal depression. NCCIH and Mayo Clinic acknowledge this evidence base.
- sumaScientific
P. paniculata root consumption significantly elevated plasma estradiol-17β and progesterone in female mice over 30 days (Oshima & Gu, 2003). Traditional use encompasses PMS, menopausal symptom relief, and hormonal balance. Pharmacological databases flag its hormonal-like effects as relevant to female reproductive health.
- tribulusScientific
Tribulus (Tribulus terrestris) has traditional use in Ayurveda and TCM for female reproductive conditions and clinical evidence from RCTs for female sexual dysfunction and endocrine infertility. Steroidal saponins (protodioscin) are proposed to modulate LH and estrogen, with clinical studies showing FSFI improvements in women with hypoactive sexual desire.
- tribulus terrestrisScientific
Tribulus terrestris has traditional use in Ayurveda and TCM for female reproductive conditions, and clinical evidence from RCTs supports use for female sexual dysfunction (FSFI improvements) and PCOS-related endocrine infertility. Its steroidal saponins (protodioscin) are proposed to modulate LH and estrogen levels.
- turmericScientific
Curcumin has been studied in RCTs for PCOS (insulin resistance, androgen levels, inflammation) and shows preclinical evidence for endometriosis. Traditional use for dysmenorrhea and menstrual disorders is documented in Ayurvedic and traditional Chinese medicine. Clinical evidence for PCOS is emerging; for endometriosis it remains preclinical.
- ubiquinolScientific
Ubiquinol supports female reproductive function through mitochondrial energy provision to oocytes, antioxidant protection of ovarian tissue, and modulation of hormonal parameters in PCOS. Clinical evidence includes IVF outcome improvements in poor ovarian responders, oocyte quality improvements in aging women, and hormone/metabolic improvements in PCOS. Ubiquinol biosynthesis declines with age and women have lower CoQ10 than men.
- valerian rootScientific
Valerian root has the most clinical evidence in the female reproductive system for primary dysmenorrhea. A 2025 systematic review and meta-analysis (PubMed PMID 40965071; 5 RCTs, n=408) found significant pain reduction with valerian versus control (SMD = −1.03; 95% CI, −1.74 to −0.33; p=0.004). Clinical trials have also examined PMS symptom severity and menopausal sleep disturbance, with modest positive findings. Proposed mechanisms include uterine smooth muscle relaxation and inhibition of prostaglandin release.
- vitamin AScientific
Vitamin A is necessary for proper female reproductive function. Deficiency impairs folliculogenesis, placentation, and fetal development. Retinoic acid initiates meiosis in the female gonad during embryogenesis. Excess preformed vitamin A is teratogenic, causing birth defects at high doses, and is contraindicated in pregnancy.
- vitamin B12Scientific
Vitamin B12 is critical to the female reproductive system through its roles in DNA synthesis, methylation, and cell division required for oocyte maturation and embryo development. Deficiency is associated with impaired embryo quality, elevated homocysteine-related implantation failure, and adverse pregnancy outcomes. B12 is also essential for placental transfer to the developing fetus.
- vitamin B6Scientific
Vitamin B6 supports female reproductive health primarily through its roles in sex hormone metabolism, serotonin synthesis, and prostaglandin regulation. It is the most studied single nutritional supplement for premenstrual syndrome and has documented clinical benefit for PMS symptoms including those related to the luteal phase.
- vitamin B9 (folate)Scientific
Folate (natural form of vitamin B9) is scientifically essential for female reproductive health, particularly periconceptional supplementation to prevent neural tube defects. It supports DNA synthesis, oocyte maturation, and implantation. WHO and NIH formally recommend folate supplementation before and during pregnancy.
- vitamin B9 (methylfolate/5-MTHF)Scientific
5-methyltetrahydrofolate (5-MTHF) is the bioactive form of folate directly used in one-carbon metabolism, with particular relevance for women with MTHFR polymorphisms who cannot efficiently convert folic acid. It supports periconceptional neural tube defect prevention and oocyte quality, and is recommended for preconception and pregnancy supplementation.
- vitamin EScientific
Vitamin E was first identified as essential for reproduction in animal models in 1922. In women, clinical trials demonstrate benefits for dysmenorrhea, PMS, endometrial thickness in implantation failure, and metabolic/hormonal parameters in PCOS. Evidence for hot flashes is covered separately.
- vitex agnus-castusScientific
Vitex agnus-castus (chasteberry) is clinically supported for PMS, PMDD, latent hyperprolactinaemia, and luteal phase deficiency via dopaminergic activity reducing prolactin. A systematic review of 12 RCTs found it superior to placebo in the majority of PMS trials. Commission E and ESCOP have issued positive monographs for menstrual cycle support.
- wheat germScientific
Wheat germ extract has been specifically tested in two clinical trials—one for primary dysmenorrhea and one for postpartum pain—both finding significant pain reduction via prostaglandin-modulating mechanisms. Its folate content is also critical for periconceptional neural tube protection. B vitamins, zinc, and vitamin E further support hormonal and reproductive health.
- yarrowScientific
Yarrow has the most comprehensive evidence base for female reproductive system support of any of its pharmacological domains. ESCOP approves it for spasms associated with dysmenorrhea; multiple clinical trials demonstrate reduced menstrual pain and PMS symptoms; and it has documented emmenagogue, antispasmodic, and in vitro estrogenic activity.
- zincScientific
Zinc is essential for female reproductive function, supporting oocyte maturation, fertilization, embryo development, and hormonal regulation. Zinc deficiency impairs FSH and LH synthesis, disrupts the menstrual cycle, and increases risk of adverse pregnancy outcomes. Clinical RCT evidence supports zinc supplementation in PCOS (improving insulin resistance and lipid balance) and in primary dysmenorrhea (reducing menstrual pain).
- agnusideTraditional
Agnuside is an iridoid glycoside and characteristic marker compound of Vitex agnus-castus, contributing to that plant's traditional and clinically studied effects on PMS, hyperprolactinaemia, and luteal phase regulation. As with other Vitex constituents, isolated clinical evidence is limited but the parent plant has substantial RCT evidence.
- alchemillaTraditional
Alchemilla (Lady's Mantle, Alchemilla vulgaris) has centuries of traditional use in European herbalism for menstrual disorders, menorrhagia, leucorrhea, and menopausal support. Its astringent tannin content provides a plausible mechanism for uterine hemostatic effects. ESCOP has issued a monograph for its traditional use in mild menstrual disorders.
- aletrisTraditional
Aletris farinosa (true unicorn root, star grass) has traditional use in North American Eclectic medicine as a female reproductive tonic, used for menstrual irregularity, amenorrhea, dysmenorrhea, and threatened miscarriage. Contains steroidal saponins. No modern clinical trials have evaluated it; classification is traditional.
- amberTraditional
Amber (Hu Po) has extensive TCM indications for the female reproductive system including dysmenorrhea, amenorrhea, irregular cycles, postpartum blood retention, and uterine masses, all attributed to blood stasis. Western traditions also regarded amber as beneficial to the uterus.
- angelicaTraditional
Angelica species (principally A. sinensis, Dong Quai) are used in TCM for female reproductive conditions including dysmenorrhea, amenorrhea, and menopausal symptoms. Angelica species contain phthalides and ferulic acid with antispasmodic and circulation-supporting properties. Clinical evidence for monotherapy is limited; primarily traditional use.
- ashokaTraditional
Ashoka (Saraca asoca) is a foundational Ayurvedic herb for female reproductive health, traditionally used for menorrhagia, dysmenorrhea, uterine disorders, and as a uterine tonic. Preclinical studies show uterotonic, estrogenic, and anti-inflammatory activities. Limited human clinical data support use in menorrhagia and leucorrhea.
- bayberryTraditional
Bayberry has documented traditional use for conditions of the female reproductive system, including excessive menstrual bleeding, uterine hemorrhage, and vaginal discharge (leukorrhea). Its astringent properties are the mechanistic basis. Multiple historical herbal references document these uses.
- bethrootTraditional
Bethroot (Trillium erectum or T. pendulum) is a traditional Native American and Eclectic medicinal plant used for uterine hemorrhage, dysmenorrhea, leucorrhea, and as a parturient aid. Contains steroidal saponins. No modern clinical trials exist; classification is traditional based on ethnobotanical documentation.
- blessed thistleTraditional
Blessed thistle (Cnicus benedictus) has traditional use in European and North American herbalism for menstrual regulation, dysmenorrhea, and as a galactagogue (lactation support). The German Commission E has approved it for loss of appetite and dyspepsia; use for female reproductive conditions is traditional. Clinical evidence for gynecological indications is limited.
- blue cohoshTraditional
Blue cohosh (Caulophyllum thalictroides) has a long history of traditional use by Native Americans and Eclectic physicians as an emmenagogue, uterine antispasmodic, and parturient herb. A US survey found 64% of midwives use it to induce labor. Scientific evidence is limited and safety concerns exist; case reports associate it with neonatal adverse events.
- borageTraditional
Borage has documented traditional use across female reproductive indications including PMS, menopause, lactation support, and menstrual disorders. GLA's role in prostaglandin modulation provides a plausible mechanism. Systematic reviews find insufficient high-quality evidence for clinical recommendation, placing this primarily in the traditional category.
- borage oilTraditional
Borage oil is traditionally used for multiple female reproductive concerns including PMS, menopause, and lactation promotion. GLA's role in prostaglandin balance and prolactin modulation provides a plausible mechanistic basis. Clinical RCT evidence specific to borage oil for female reproductive endpoints is lacking; most evidence is traditional and mechanism-based.
- bugbaneTraditional
Bugbane (Actaea/Cimicifuga species, including A. racemosa syn. Cimicifuga racemosa) encompasses several species traditionally used by Native Americans for female reproductive conditions, menstrual cramps, and labor support. The most studied species (black cohosh) has RCT evidence; the traditional use of the broader 'bugbane' category is primarily traditional.
- bupleurum falcatumTraditional
B. falcatum is a central herb in TCM for female reproductive conditions, used in the most widely prescribed women's health formulas (Xiao Yao San, Jia Wei Xiao Yao San) for menstrual irregularity, PMS, menopause, and uterine disorders. A clinical trial of a B. falcatum-dominant formula showed efficacy for menopausal symptoms.
- calendulaTraditional
Calendula is classified as an emmenagogue, uterine tonic, and antispasmodic across Ayurvedic, Unani, Western, and Eclectic herbal traditions. It is used for menstrual irregularity, dysmenorrhoea, leucorrhoea, and vaginitis. The ESCOP cites clinical evidence for vaginal candidiasis specifically.
- cassia barkTraditional
Cassia bark is one of the most consistently cited TCM herbs for female reproductive complaints including menstrual irregularities, amenorrhea, menstrual cramps, and dysmenorrhea due to cold-type patterns. RxList lists menstrual problems and menopausal symptoms among traditional oral uses. No clinical trials targeting female reproductive endpoints were identified.
- casticinTraditional
Casticin is a methoxyflavone and primary bioactive constituent of Vitex agnus-castus, contributing to that plant's well-documented female reproductive effects (PMS, hyperprolactinaemia, luteal phase deficiency). Preclinical evidence shows hormone-receptor interactions and anti-inflammatory activity; isolated human clinical evidence is limited but supported by the parent plant's RCT data.
- catjang cowpeaTraditional
Traditional use of cowpea for dysmenorrhea (painful menstruation) and as a strengthening food for pregnant women is documented in African and Asian folk medicine. Ayurvedic texts record cowpea as increasing breast milk production. No clinical evidence exists.
- celeryTraditional
Celery has traditional use in Ayurvedic and Western herbal medicine as an emmenagogue and antispasmodic for menstrual regulation and dysmenorrhea. Apiol in celery seed is traditionally regarded as antispasmodic for smooth muscle. Clinical data come only from a multi-ingredient combination product trial.
- chaff flowerTraditional
A. aspera is used in Ayurveda for menstrual disorders, as an emmenagogue, and has documented abortifacient properties. Traditional use for gynecological disorders including dysmenorrhea and facilitating delivery is widespread.
- clary sageTraditional
Clary sage (Salvia sclarea) is used in aromatherapy and European herbal medicine for dysmenorrhea, menstrual regulation, and labor support. Its essential oil contains sclareol, a phytoestrogenic compound. Limited clinical evidence from small studies suggests inhalation may reduce dysmenorrhea and cortisol. Classification is primarily traditional.
- clematisTraditional
Clematis armandii and C. montana ('Chuan Mu Tong') are recorded in the Chinese Pharmacopoeia and TCM materia medica to 'stimulate menstrual flow and promote lactation' (galactogogue) and to address amenorrhea. These are well-documented traditional indications. No clinical evidence exists.
- cnidiumTraditional
Cnidium monnieri (She Chuang Zi) is a traditional Chinese herb used for female reproductive conditions including leucorrhea, vaginal itching, and menstrual irregularity. Contains osthole, a coumarin with demonstrated estrogenic and antiparasitic activity. Used topically and internally in TCM for gynecological conditions.
- commiphoraTraditional
Commiphora myrrh is documented as an emmenagogue in Unani, Ayurvedic, Chinese, and Arabic medical traditions, used for amenorrhea, dysmenorrhea, menorrhagia, and pelvic inflammatory disease. No human RCTs for gynecological indications have been published.
- cordycepsTraditional
Cordyceps (Cordyceps sinensis and C. militaris) is a traditional Chinese tonic mushroom used for female reproductive conditions including irregular menses, infertility, and menopausal fatigue. Active nucleosides and polysaccharides modulate the HPG axis. Limited clinical evidence exists for specific female reproductive endpoints; primarily traditional.
- cramp barkTraditional
Cramp bark (Viburnum opulus) has documented traditional use in North American herbalism as a uterine antispasmodic for dysmenorrhea and uterine cramping. Preclinical studies including human uterine tissue experiments confirm relaxant effects. No randomized clinical trials have been conducted for human gynecological endpoints.
- cynomoriumTraditional
Cynomorium coccineum (Suo Yang) is used in TCM and traditional Mediterranean medicine as a tonic for reproductive vitality. In TCM it is prescribed for female reproductive deficiency, menstrual irregularity, and menopausal complaints. Preclinical evidence shows estrogenic and antioxidant activity. Clinical human evidence is limited; classification is primarily traditional.
- damianaTraditional
Damiana (Turnera diffusa) has traditional use in Mexican, Native American, and Mayan medicine as a female aphrodisiac, emmenagogue, and reproductive tonic. It has been used to increase female libido, regulate menstruation, and support hormonal balance. Phytoestrogenic flavonoids are present; clinical evidence is limited but animal studies confirm aphrodisiac activity.
- dandelionTraditional
Dandelion (Taraxacum officinale) has traditional use in European and North American herbalism as a supportive herb for female reproductive conditions, particularly for liver support (facilitating estrogen metabolism/clearance), PMS-related water retention, and as a nutritive tonic. Clinical evidence specifically for female reproductive endpoints is limited; primary use is traditional.
- devil's clawTraditional
Devil's Claw has documented traditional use related to the female reproductive system, including use in childbirth/midwifery, for menstrual problems, and as a traditional oxytocic. These uses are recorded in multiple ethnobotanical sources. No clinical trials exist for reproductive system outcomes.
- dioscoreaTraditional
Dioscorea (wild yam) has extensive traditional use for dysmenorrhea, menopausal symptoms, and uterine cramping across Native American, TCM, and Ayurvedic traditions. Its steroidal saponin diosgenin is a progesterone precursor industrially, but in vivo conversion in humans is not demonstrated. One RCT found no significant benefit for menopausal symptoms versus placebo.
- diosgeninTraditional
Diosgenin is a steroidal saponin found in wild yam (Dioscorea species) and fenugreek, traditionally used in female reproductive contexts. It structurally resembles progesterone and was historically the precursor for industrial synthesis of steroidal hormones. Its phytoestrogenic activity supports ovarian function; however, direct human conversion to hormones in vivo has not been demonstrated.
- dogwoodTraditional
Cornus officinalis is traditionally used in TCM for menorrhagia, leukorrhea, and reproductive deficiency in women. Jamaican dogwood is traditionally used for dysmenorrhea and uterine/ovarian spasm. Both uses are documented across herbal pharmacopeias, though human trial evidence is absent.
- dong quaiTraditional
Dong quai (Angelica sinensis) has been a cornerstone of Traditional Chinese Medicine for female reproductive health, used for menstrual irregularities, dysmenorrhea, and as a 'female tonic.' Scientific evidence for menopausal symptoms as a monotherapy is weak; a double-blind RCT found no estrogenic effect vs. placebo. Most use is in multi-herb formulations.
- dong quai rootTraditional
Dong quai root is the primary preparation of Angelica sinensis used in Traditional Chinese Medicine for female reproductive conditions including menstrual irregularity, dysmenorrhea, and menopausal complaints. Clinical evidence as monotherapy is limited; one placebo-controlled RCT found no estrogenic activity versus placebo.
- evening primrose oilTraditional
Evening primrose oil (EPO) is rich in gamma-linolenic acid (GLA) and linoleic acid (LA), used traditionally and in practice for PMS, menopausal hot flushes, cervical mucus quality, and hormonal balance. Clinical evidence is limited; an RCT found oral gamolenic acid modestly reduced menopausal flushing vs. placebo. It is also used for cyclic mastalgia.
- false unicorn rootTraditional
False unicorn root (Chamaelirium luteum) has extensive traditional use in North American herbalism as a female reproductive tonic for ovarian dysfunction, threatened miscarriage, morning sickness, and hormonal imbalance. Contains steroidal saponins including chamaelirin. Scientific clinical evidence is very limited; use is primarily based on 19th-century Eclectic tradition.
- feverfewTraditional
Feverfew has one of its strongest traditional associations with female reproductive complaints, including menstrual regulation, dysmenorrhea, and labor. The NCCIH, PMC systematic review, and ethnobotanical records from Greco-Roman, European, Mexican, and Andean traditions all document this. No clinical trials address reproductive endpoints.
- fo-tiTraditional
Fo-ti (Polygonum multiflorum, He Shou Wu) is a TCM herb with traditional use for female reproductive tonification, anti-aging, and addressing kidney-liver deficiency patterns including those manifesting as menstrual irregularity and menopausal symptoms. Stilbene glycosides are proposed active compounds. Hepatotoxicity cases limit use.
- giant trilliumTraditional
Giant trillium (Trillium chloropetalum or related species) has traditional use in Native American medicine for female reproductive conditions including uterine hemorrhage and as a parturient preparation, similar to bethroot (T. erectum). Classification is traditional based on ethnobotanical records; no modern clinical evidence exists.
- golden ragwortTraditional
Golden ragwort (Packera aurea, formerly Senecio aureus) was a major traditional North American Eclectic medicine herb for female reproductive disorders, used for dysmenorrhea, amenorrhea, and uterine disorders. Contains pyrrolizidine alkaloids which are hepatotoxic; modern use is discouraged. Classification is traditional with significant safety concerns.
- goldensealTraditional
Goldenseal is traditionally used for conditions of the female reproductive system including vaginal infections, uterine inflammation, and heavy periods, with documented historical use as a vaginal douche and for hemorrhagic conditions. Modern use in a vaginitis device (Cerviron) provides some clinical context.
- gravel rootTraditional
Gravel root was traditionally used as a uterine tonic and partus preparator by Native American tribes and Eclectic physicians, and is recorded for chronic uterine disease, painful periods, and pelvic organ debility. No clinical studies exist.
- horny goat weedTraditional
Horny goat weed (Epimedium species) is a traditional Chinese medicine herb used for female and male reproductive conditions including low libido and menopausal complaints. Icariin, its principal flavonoid, demonstrates phytoestrogenic ERβ activity and inhibits phosphodiesterase-5. Traditional TCM use spans centuries; clinical evidence in women is limited.
- hyacinth beanTraditional
Ayurvedic use of L. purpureus flowers to promote menstruation and treat uterine inflammation, TCM use of the seed for excessive leucorrhoea, and Karbi tribal use of roots as an antifertility/abortifacient agent collectively establish documented traditional use across the female reproductive system.
- lady's mantleTraditional
Lady's Mantle (Alchemilla vulgaris) is a traditional European herb used for centuries for menorrhagia, dysmenorrhea, leucorrhea, and menopausal complaints. High tannin content provides astringent and hemostatic activity relevant to uterine mucosa. Traditional use is extensively documented but modern clinical trial data are absent.
- leptadeniaTraditional
Leptadenia reticulata (Jivanti) is an important Ayurvedic herb used as a female reproductive tonic, galactagogue, and for treating leucorrhea and menstrual disorders. Preclinical studies confirm estrogenic activity and galactopoietic effects. Listed in traditional Indian medicine databases for female reproductive support.
- ligusticumTraditional
Ligusticum chuanxiong (Chuan Xiong) is a key TCM herb for female reproductive conditions including dysmenorrhea, irregular menses, and postpartum blood stagnation. Contains phthalides (Z-ligustilide, butylidenephthalide) with uterotonic and antispasmodic activity. Used in classical formulas such as Si Wu Tang for menstrual regulation.
- lotus seedTraditional
TCM documents lotus seeds for female reproductive conditions including heavy menstruation, leukorrhea, and vaginal discharge through kidney-astringent mechanisms. No pharmacological or clinical studies have examined female reproductive endpoints specifically.
- momordicaTraditional
Momordica charantia is documented in traditional medicine as an emmenagogue, galactagogue, and treatment for dysmenorrhea, leucorrhea, and menstrual irregularities. Animal studies show abortifacient activity. Traditional galactagogue use is documented across South Asia. Human clinical evidence is absent and safety in pregnancy/lactation is uncertain.
- morindaTraditional
M. officinalis is classified in TCM as 'warming the uterus' and tonifying kidney yang to support female reproductive function, including treatment of menstrual irregularities, infertility, and uterine coldness. These traditional indications are consistently documented across ethnopharmacological reviews. Estrogen-like activity of the root has been proposed as a potential mechanism.
- motherwortTraditional
Motherwort (Leonurus cardiaca) has traditional use in European and Chinese herbal medicine for menstrual irregularity, amenorrhea, and uterine tonic effects. It contains alkaloids (leonurine) that demonstrate uterotonic activity in preclinical studies. Scientific evidence in humans is limited; it is classified as primarily traditional for female reproductive use.
- oreganoTraditional
Oregano is one of the most consistently documented emmenagogue herbs in Western herbal tradition, with its use for promoting menstruation, relieving menstrual cramps, and addressing PMS symptoms documented from ancient Greek medicine through 19th-century Eclectic medical practice. Multiple traditional medicine systems independently record this application. No human clinical trials for reproductive endpoints have been published.
- oriental arborvitaeTraditional
P. orientalis is documented in multiple authoritative sources as used for female reproductive conditions including menorrhagia, irregular periods, menstrual cramps, and dysfunctional uterine bleeding. The Chinese Pharmacopoeia lists dysfunctional uterine bleeding as an indication for Platycladi cacumen. WebMD/NLM confirm these traditional uses.
- PABA (para-aminobenzoic acid)Traditional
PABA has a documented historical use for female infertility, attributed to possible enhancement of estrogenic activity. The sole primary clinical report is a 1942 uncontrolled series by Sieve in which 75% of 16 infertile women became pregnant during PABA supplementation. No modern studies have reproduced this and it remains a traditional claim.
- parsleyTraditional
Parsley has extensive traditional use across the female reproductive system: as an emmenagogue for delayed menstruation, uterine stimulant, mild remedy for dysmenorrhoea, and antigalactagogue during lactation. The compounds apiol and myristicin are responsible for uterine stimulant effects, documented across multiple historical and folk medicine systems.
- partheniumTraditional
Feverfew has one of its most historically deep-rooted traditional applications in female reproductive health, including menstrual regulation, menstrual cramp relief, promotion of uterine contractions, and management of labor. The NCCIH lists menstrual disorders and infertility as traditional uses. No clinical RCTs address reproductive endpoints specifically.
- passionflowerTraditional
Passionflower (Passiflora incarnata) has traditional use in North American and European herbalism for menopausal anxiety, insomnia, and PMS-related mood symptoms. Some clinical evidence supports its anxiolytic effects relevant to menopausal nervous symptoms. Not a direct uterine or hormonal herb; rather supports the nervous system component of female reproductive transitions.
- peachTraditional
Peach kernel (Tao Ren) is one of the most important TCM herbs for female reproductive conditions, used for irregular menstruation, dysmenorrhea, postpartum blood stasis, and amenorrhea. It is a principal ingredient in multiple classical gynecological formulas.
- pennycressTraditional
Pennycress has extensive traditional documentation for female reproductive conditions, including dysmenorrhea, endometriosis, post-partum pain, menstrual irregularities, and womb disorders. The plant was classified as an emmenagogue and was used across Chinese, Tibetan, and European herbal traditions for gynecological complaints.
- pennyroyalTraditional
Pennyroyal (Mentha pulegium) has a very long history of traditional use as an emmenagogue (to stimulate menstrual flow) and abortifacient in European, Native American, and other traditions. Its active compound pulegone is toxic at higher doses and has caused fatalities; professional herbalists and health authorities caution strongly against its use for reproductive purposes.
- peonyTraditional
White peony root (Paeonia lactiflora, Bai Shao) is a foundational TCM herb for female reproductive disorders including dysmenorrhea, menstrual irregularity, PCOS, and menopausal complaints. The active compound paeoniflorin modulates gonadotropin release and inhibits androgen production. Used in classical formulas like Gui Zhi Fu Ling Wan and Shao Yao Gan Cao Tang.
- pituitary substanceTraditional
Pituitary substance has been used in glandular therapy traditions to support female reproductive function, given the pituitary's secretion of FSH, LH, and prolactin — the hormones governing the menstrual cycle, ovulation, and lactation. This use dates to early 20th-century organotherapy. No modern clinical evidence supports oral supplementation for this system.
- raspberryTraditional
Red raspberry leaf (Rubus idaeus) has extensive traditional use as a uterine tonic, partus preparator for the last trimester of pregnancy, and for menstrual discomfort. It is widely used by midwives and pregnant women. Limited clinical evidence exists; one RCT showed it may reduce labor duration. Classification is primarily traditional.
- rehmanniaTraditional
Rehmannia glutinosa (Di Huang) is a foundational TCM herb used in female reproductive formulas for menstrual irregularity, menopausal symptoms, and uterine bleeding. The dried root (Shu Di Huang) nourishes 'yin and blood' in TCM. Iridoid glycosides including catalpol demonstrate neuroprotective and hormonal modulating effects in preclinical studies.
- rehmannia glutinosaTraditional
Rehmannia glutinosa is the specific botanical name for the TCM herb Di Huang (Chinese foxglove root), fundamental to female reproductive formulas in Traditional Chinese Medicine. It supports yin-blood and is used for menopausal symptoms, uterine bleeding, and menstrual irregularity. Preclinical evidence shows hormonal and anti-inflammatory activity.
- sarsaparillaTraditional
Sarsaparilla has documented traditional use in women's health for menstrual support, menopause symptom management, and as a reproductive tonic, noted in PeaceHealth and documented across South American, Mexican, and Asian traditions. A progesterone-like effect is historically claimed but remains unverified. Estrogenic and antiestrogenic activities have been described for at least one Smilax species.
- saw palmettoTraditional
Saw palmetto has a centuries-long traditional use in female reproductive health, including treatment of painful menstruation, infertility, underdeveloped breasts, and increased lactation. Modern interest centers on its antiandrogenic properties for PCOS-related hyperandrogenism, but direct high-quality RCTs in women remain absent. Its mechanistic rationale via 5-alpha-reductase inhibition and potential antiestrogenic/antiandrogenic balance is documented.
- shepherd's purseTraditional
Shepherd's purse (Capsella bursa-pastoris) has traditional use in European and TCM herbalism as a uterine hemostatic and oxytocic agent for menorrhagia, postpartum hemorrhage, and irregular menses. Preclinical evidence confirms oxytocic and hemostatic activity. Clinical evidence in humans is limited; traditional use spans thousands of years across multiple traditions.
- sichuan lovageTraditional
Sichuan Lovage (Ligusticum chuanxiong, Chuan Xiong) is a major TCM herb for female reproductive conditions including dysmenorrhea, amenorrhea, and postpartum pain. Its phthalide compounds (Z-ligustilide) mediate uterine antispasmodic and blood-activating effects. It is a primary ingredient in classical TCM gynecological formulas.
- smartweedTraditional
Smartweed has documented traditional use for multiple female reproductive conditions including menorrhagia, dysmenorrhea, menstrual irregularities, and fertility regulation, across European, South Asian, and East Asian medical traditions. Limited animal studies support antifertility effects.
- solomon's sealTraditional
Solomon's seal is a documented female reproductive tonic across Western eclectic, Ayurvedic, indigenous North American, and TCM traditions, with applications including menorrhagia, leukorrhea, menstrual cramps, vaginal dryness, fertility support, and postpartum recovery.
- squawvineTraditional
Squawvine (Mitchella repens) is a traditional Native American herb used for centuries to tone the uterus, facilitate labor, and address menstrual irregularity. It was widely used by Cherokee and other Indigenous peoples and later adopted by Eclectic physicians for uterine preparation before childbirth. Modern clinical evidence is absent; use is purely traditional.
- szechuan lovageTraditional
CX is one of TCM's most important herbs for female reproductive health, used for over 2,000 years for menstrual disorders, dysmenorrhea, amenorrhea, and postpartum blood stasis. Its uterine smooth muscle-relaxing ligustilide provides a pharmacological mechanism, and CX is a primary ingredient in classical gynecological formulas. Clinical trial evidence for reproductive endpoints specifically is limited.
- vanillaTraditional
Vanilla has a multi-century traditional use for menstrual disorders including dysmenorrhea (menstrual cramps), amenorrhea, and uterine spasms. These uses are documented in Aztec medicine, 18th-century European pharmacopoeias, and multiple herbalist monographs. No clinical or preclinical reproductive system studies have been conducted.
- viburnumTraditional
Viburnum species (cramp bark V. opulus; black haw V. prunifolium) have traditional use in North American and European herbalism as uterine antispasmodics for dysmenorrhea and threatened miscarriage. Animal and human uterine tissue studies confirm antispasmodic effects. No randomized clinical trials have evaluated efficacy for PMS or dysmenorrhea in humans.
- vitexicarpinTraditional
Vitexicarpin (casticin) is a flavonoid isolated from Vitex agnus-castus (chaste tree), contributing to that plant's female reproductive effects. Preclinical studies demonstrate anti-inflammatory, antiproliferative, and hormone-modulating properties relevant to uterine and ovarian function. It is primarily characterized through its parent plant's traditional and clinical use.
- wild yamTraditional
Wild yam has long traditional use for female reproductive complaints including dysmenorrhea, PMS, and menopausal symptoms across Native American and European traditions. The steroidal saponin diosgenin is structurally related to progesterone. However, one double-blind RCT found no effect on menopausal symptoms, and human in vivo conversion of diosgenin to hormones is unproven.
- wood betonyTraditional
Wood betony is documented as an emmenagogue and uterine tonic with traditional use for menstrual regulation, dysmenorrhoea, PMS, menopausal symptoms, and uterine congestion. Traditional Austrian medicine recorded its use for gynaecological problems.